A B S T R A C T The phytohemagglutinin (PHA) response of lymphocytes from untreated patients with systemic lupus erythematosus (SLE) was studied using highly purified subpopulations of cells involved in the transformation response: T lymphocytes, B lymphocytes, and monocytes. Cell transformation was quantitated using both tritiated thymidine ( 
quantitated using both tritiated thymidine ( 19: 827. (Abstr.) Receivedfor publication 12 November 1976 and in revised form 26 April 1977. hypocomplementemic patients were stimulated on either autologous or normal allogeneic monocyte monolayers. Likewise, normal lymphocytes incorporated similar amounts of [3H]TdR and had similar percentages of cells in S, G2, and M phases whether their T lymphocytes were stimulated on autologous or SLE monocyte monolayers. Highly purified subpopulations of B and T lymphocytes were obtained by density sedimentation or Fenwal Leuko-Pak passage of lymphocyte populations. The response to PHA by lymphocytes from the hypocomplementemic lupus patients could be seen to involve at least two abnormalities. One, in reference to normal lymphocytes, SLE T lymphocytes plus monocytes had an impaired response; two, SLE B lymphocytes plus SLE T lymphocytes plus SLE monocytes had an impaired response. Two patients in the hypocomplementemic group were treated with steroids. 5 days after steroid treatment was initiated, the percentage of cells in S, G2, and M phases and the [3H]TdR response of PHA-stimulated lymphocytes returned to normal. The normalization of the [3H ]TdR response was explained both by a return of purified T cells plus monocytes, purified B cells plus monocytes, and whole lymphocyte populations to normal responsiveness. These studies suggest that a steroid-correctable defect exists in T and B lymphocytes in SLE.
INTRODUCTION
Systemic lupus erythematosus (SLE)1 was originally described as an inflammatory disorder of connective tissue, blood vessels, and serosal surfaces (1) . Following the insight provided by the elucidations of the immunologic mechanisms involved in the formation of the LE cell, autoantibodies with binding affinities for various nuclear, cytoplasmic, cellular, and protein antigens have been described (2) , and there is strong evidence that antigen-antibody complexes play a central role in the induction of tissue injury (3) .
It has been suggested that defects in cell-mediated immunity may play a role in the development of autoimmune disease. Studies of the NZB-NZW mouse indicate that autoantibody formation is preceded by T-cell dysfunction (4) suggesting a primary immunoregulatory abnormality of cellular immunity.
We have examined cellular immunity in an untreated group of SLE patients. Lymphocyte responsiveness to phytohemagglutinin (PHA) was assessed using purified populations of T lymphocytes, monocytes, and B lymphocytes in the PHA response of cells from 14 patients. Responsiveness was assessed by both tritiated thymidine ([3H ]TdR) incorporation and relative cellular DNA content determined by cytofluorography.
METHODS
Patients. All of the 14 patients studied had at least four of the preliminary criteria of the American Rheumatism Association (ARA) for the diagnosis of SLE (5). Their mean age was 25 yr, and 13 patients were females. At the time of study, no patient had taken any drug other than aspirin or birth control pills for the previous 3 wk. In particular, no patient was being treated with cytotoxic drugs or steroids. All patients agreed to take no medication (including aspirin and oral contraceptives) for 2 days before the study. The control group consisted of 15 normal females with a mean age of 29 yr. None had taken any drugs for 5 days before the study.
The patients were arbitrarily divided into two groups on the basis of the serum complement. As outlined in Table II , those patients with hypocomplementemia (defined as a serum C3 < 90 mg/dl) had a longer disease duration, a higher mean number of preliminary ARA diagnostic criteria, a larger number with fever, anti-DNA antibodies, higher serum creatinine, lower peripheral blood lymphocyte counts, and a larger number with lymphocytotoxic antibodies. In general, the disease seemed more active in hypocomplementemic patients. Antisera. Serum and urine were obtained from patients with an established diagnosis of multiple myeloma or macroglobulinemia. Monoclonal proteins were isolated by preparative zone electrophoresis, using polyvinyl copolymer as supporting medium in barbital buffer pH 8.6, T/2 0.1. Proteins were further purified on Sephadex G-200 or Bio-Gel A 1.5 m 100-200 agarose gel (Bio-Rad Laboratories, Richmond, Calif.) equilibrated with 0.1 M Tris-0.5 M NaCl. Protein concentrations were determined by the Folin-Lowry technique (6). A polyvalent antiserum specific for y-, ,-, K-, and X-chains was prepared in a goat immunized with a mixture of purified IgM, X-, and IgG, K-proteins. The antiserum obtained showed reactions of identity for a panel of purified IgG, IgM, and K-, or X-Bence-Jones proteins. Monospecific antisera to IgG were prepared in New Zealand albino rabbits by immunization with purified IgGl, X-myeloma proteins and absorption with purified X-Bence-Jones protein. Antisera obtained gave a reaction of identity with 16 purified IgG myeloma proteins (four from each IgG subclass), and showed heavy chain specificity for both Fc and Fab fragments. IgG was purified from monospecific antisera by DEAE-Sephadex ion-exchange chromatography using elution with 0.005 M phosphate buffer, pH 7.2. Pepsin digestion of purified rabbit or goat IgG was carried out in acetate buffer at pH 4.5 using ratios of crystalline pepsin/protein (wt/wt) of up to 3% for 72 h to obtain virtually complete digestion of IgG. Digestion was monitored by Ouchterlony analysis using antisera to rabbit and goat IgG having specificity for the Fc region. Fragments were then purified on a calibrated Sephadex G-150 column equilibrated with phosphate-buffered saline, pH 7.2, for separation of undigested IgG, F(ab')2, Fab', PFc', and peptides. The purified F(ab')2 was harvested from fractions of -100,000 mol wt with exclusion of all overlap fractions containing undigested IgG. Balanced specificity for y, ,u, K, and X was achieved by the addition of purified rabbit F(ab')2 with K specificity. The polyvalent and IgG F(ab')2 antisera were conjugated with fluorescein or rhodamine using 30 ug/mg of protein in saline-carbonate-bicarbonate buffer 0.5 M, pH 9.0, with removal of unbound fluorochrome by exhaustive dialysis or filtration through G-25 Sephadex. The fluorescein/protein ratios for antisera were between 2 and 3. Specificity was reassessed, titered by Ouchterlony analysis, and confirmed by specific blocking of direct and indirect immunofluorescence only with purified proteins of the designated specificity as previously described (7) .
Aggregate (Fc) receptor-bearting cell enumeration. The Fc receptor was identified as previously described using the modifications of Yount et al. (7) and Dickler (8) Surgace Ig-bearing cell enumeration. Staining for surface immunoglobulins was carried out as previously described (9) using the purified F(ab')2 antisera as described by Winchester et al. (10) . Lymphocytes in a concentration of 1-2 x 106 in 0.5 cm3 of 10%o FCS-RPMI 1640 were incubated with 0.05-0.10 ml of fluorochrome-conjugated F(ab')2 polyvalent anti-human immunoglobulin in 10 x 75-mm glass tubes for 1 h at 4°C, washed three times with a total of 10 ml of cold FCS-RPMI, and mounted on glass slides. The cells were overlaped with a cover slip, sealed, and 1,000 cells were counted with a Leitz ultraviolet microscope equipped with a mercury arc lamp (E. Leitz, Inc., Rockleigh, N. J.), using BG 38-and 490-nm (fluorescein isothiocyanate) exciter filters and a K510-nm barrier filter, by epi-illumination and simultaneous phase-contrast microscopy to identify all nonstaining cells.
T-cell enumeration. Spontaneous cold sheep erythrocyte (E) rosettes were assayed by a variation (9) (14) . Purification of T lymphocytes. T cells were purified by three techniques, as outlined in Fig. 1 . The first purification method was a modification of the method of Julius et al. (15) . 300 mg of nylon wool (Leuko-Pak, Fenwal Laboratories, Morton Grove, Ill.), soaked in normal saline for 4 days at 37°C, was loosely packed into a 3-ml syringe, and then washed with 20 ml RPMI and 10 ml RPMI-10% FCS. The outflow was sealed, 10 ml RPMI-10% FCS was added, and the syringe was placed upright in an incubator at 37°C for 30 min. After draining this medium, 5 x 107 mononuclear cells in 1 ml RPMI were added dropwise, and incubated for 30 min at 37°C. (16) . Aliquots of 5 x 106 E-rosetted lymphocytes/ml RPMI were layered over 3 ml of F-H (d, 1.09 g/ml) at room temperature and centrifuged at 1,200g for 30 min. The pelleted cells were collected, the erythrocytes were lysed by addition of distilled water followed rapidly by flooding with RPMI, and the mononuclear cells were respun on F-H. The interface cells were washed twice in RPMI-1640 and resuspended to 1 x 106/cm3. These cells were designated E-RFC(b).
The third method of purification was a modification of the method of Parish and Hayward (16) . Aliquots of 5 x 106 EAC-rosetted lymphocytes/ml RPMI-10% FCS at room temperature were layered over 3 ml F-H (d, 1.09 g/ml) at room temperature and centrifuged at 1,200 g for 30 min. The interface cells were collected, washed twice in RPMI-1640, and resuspended to 1 x 106/ml with RPMI. These cells were designated E-RFC(c).
Purification of B lymphocytes. B cells were purified by three techniques, as outlined in Fig. 1 . The first and second purification methods were modifications of the method of Greaves and Brown (17) . Aliquots of 5 x 106 E-rosetted lymphocytes/ml RPMI-10% FCS at room temperature were layered over 3 ml of F-H (d, 1.09 g/ml) at room temperature and centrifuged at 1,200g for 30 min. The interface cells were washed once at room temperature in RPMI-1640, spun at 300 g, and rosetted with sheep erythrocytes exactly as described above, and recentrifuged over F-H. The interface cells were collected, layered over 3 ml of F-H at room temperature, and centrifuged at 1,200 g for 30 min. The interface cells were then washed twice in RPMI-1640 and resuspended to 1 x 106/ml. These cells were designated Benriched(d). In some cases, a third E-rosetting was performed; these cells were designated B-enriched(f).
The third purification method was a modification of the method of Parish and Hayward (16) . Aliquots of 5 x 106 EAC-rosetted lymphocytes/ml RPMI-10% FCS at room temperature were layered over 3 ml F-H (d, 1.09 g/ml) at room temperature and centrifuged at 1,200g for 30 min. The pelleted cells were resuspended, the erythrocytes lysed by addition of distilled water followed rapidly by flooding with RPMI, and then recentrifuged over F-H. The interface cells were washed twice in RPMI-1640 and resuspended to 1 x 106/ml with RPMI. These ceTls were designated B-enriched(e).
Monocyte isolation and preparation. Monocytes were isolated by peripheral blood mononuclear cells by attachment to the plastic surface of tissue culture tubes. 1 x 106 peripheral blood mononuclear cells were added to each culture tube in RPMI-1640 and placed in a 95% air-5% CO2 incubator for 2 h. The cell suspension was discarded and the tubes were washed four times with RPMI to remove nonadherent cells; recovery was =10%. More than 98% of the adherent cells (removable by vigorous washing) were monocytes, having used latex phagocytosis and a-naphthylacetate staining as criteria. In two experiments, 1 x 105, 5 x 106, 1 x 106, and 5 x 106 peripheral blood mononuclear cells were added to different culture tubes (effecting monocyte layers of roughly 1 x 104, 5 x 104, 1 x 105, and 5 x 106 cells).
In some experiments, peripheral blood mononuclear cells were irradiated with 2,500 rads before use in culture as a monocyte source. Mitomycin C treatment was performed by adding 50 ,ug/ml mitomycin C to 5 x 106 peripheral blood mononuclear cells/ml for 30 min at 37°C, and washing three times in RPMI-1640.
Mitogen culture. The optimal dose ofPHA and the optimal number of lymphocytes was initially determined by culturing for 2, 3, 4, and 5 days with PHA concentrations of 0.05, 0.5, 1, 2, 5, and 50 ,ug and SLE or normal mononuclear cells with a final cell concentration of 1 x 104, 1 x 105, 3 x 105, 5 x 106, and 1 x 106 cells/ml. Before culture, the mononuclear cells were washed three times at 37°C and incubated at 37°C for 12 h. All cultures were done in duplicate at 37°C in a 5% CO2 atmosphere, and the optimal dose of PHA and the optimal concentration of lymphocytes was selected by determining the cell number and lectin concentration which resulted in the highest uptake of After determining the optimal dose of lectin and cell number, all cultures using purified mononuclear cells and lymphocyte subpopulations were performed as described. RPMI 1640 with 10% heat-inactivated, fresh frozen pooled human AB+ serum and 50 ,ug/ml of gentamycin (Microbiological Associates, Bethesda, Md.) was the medium. The mononuclear cells and purified lymphocyte subpopulations were always washed three times at 37°C and incubated at 37°C for 12 h before culture. Quadruplicate cultures of 1.0 x 105 mononuclear cells or purified lymphocyte subpopulations in a 1-ml medium were made in 10 x 75-mm, sterile, capped tissue culture tubes (Falcon Plastics, Div. ofBioQuest, Oxnard, Calif.) in a 37°C, 5% CO2 atmosphere. PHA (Burroughs Wellcome, Co., Research Triangle Park, N. C.) at 0.5 ,ug/culture was added in a volume of 0.5 ml medium. Duplicate cultures were terminated on days 0 (after 2 h), 1, 2, 3, 4, and 5 days after a 5-h pulse with 1 ,uCi of [3H]TdR (New England Nuclear, Boston, Mass.). The trichloroacetic acid-insoluble radioactivity ofcells was collected on Millipore filters (HAMK, Millipore Corp., Bedford, Mass.) and counted in a liquid scintillation counter. All data are expressed as the maximum difference between the counts per minute (cpm) in the stimulated culture and the cpm in the control culture. To determine the maximal difference in cpm, the difference in cpm for each day of culture and each concentration of mitogen was determined and the largest (maximal) differences in cpm used for comparison. Thus, the cpm in each figure represent the group mean derived from the maximal difference in cpm of each individual determination.
Cell staining and cytofluorograph instrumentation. Duplicate tubes of the PHA-stimulated mononuclear cells or lymphocytes were stained as previously described with ethidium bromide, a general nucleic acid stain, by the method of Gohde and Dittrich (18) [3H ]TdR incorporation by normal and SLE lymphocytes. In Fig. 2 , a significantly decreased incorporation of [3H ]TdR can be noted in the lupus population on culture days 2, 3, 4, and 5 (P < 0.0025). The thymidine doubling time was estimated to be 12 h in the normal population and 16 h in the lupus population, when calculated from several points on the curve during the 2nd day of culture.
Cytofluorography of normal and SLE lymphocytes. To eliminate the possibility that the decrease in the incorporation of [3H ]TdR in the lupus population was simply due to an abnormality in the thymidine transport system, the cellular DNA content of the lupus lymphocytes was determined cytofluorometrically. In Fig. 3 , a marked discrepancy is seen between the lupus population and the normal mononuclear cells. The kinetics of cell proliferation using cytofluorography closely parallel the kinetics when using thymidine incorporation, suggesting that this method may be used alternatively to thymidine incorporation as a means of assessing DNA synthesis.
Effect of disease activity on lymphocyte transformation in hypo-and normocomplementemic patients. The SLE patients were divided into two groups, based on the presence of hypocomplementemia (Table II) . The cytofluorographically were studied (Fig. 4) , a striking difference between the two populations of patients was seen (P < 0.0005). cytes to the abnormal proliferative response was then examined. The effect of adding normal B lymphocytes to autologous T lymphocytes cultuLred on autologous monocyte monolayers was studied (Fig. 7) . In this experiment, it can be seen that a statistically significant increase in thymidine incorporation occurs when B lymphocytes are added to the culture system (P < 0.0005 on day 3). This B-cell helper effect can be expressed by the increase in [3H]TdR uiptake of 16_ 'c/ 8I Effect of steroid treatment. Two of the original group of seven hypocomplementemic lupus patients were subsequently treated with steroids (1 mg/kg oral prednisone) because of persistent abnormalities in urine sediment and rising serum creatinine. These patients were studied seriall' after the institution of corticosteroid therapy. Normalization of the kinetics of thymidine incorporation and DNA synthesis, which occurred in the lymphocytes of both patients within 5 days after treatment was initiated (Fig. 9) , was striking. This normalization of the kinetic response of the cells was independent of any change in clinical status since the urinalysis and serum creatinine remained abnormal for several weeks after treatment was started. In both of these patients, purified T and B lymphocytes responded normally to PHA and Blymphocyte helper function was normal. A similar increase in lymphocyte [3H ]TdR incorporation was not noted in three patients with rheumatoid vasculitis and decreased lymphocyte [3H ]TdR incorporation who were also treated with 1 mg/kg prednisone.
DISCUSSION
Studies of cell-mediated immunity in SLE reveal significant discrepancies (26) (27) (28) (29) (30) (31) (32) (33) (34) . Some of the reasons for these discrepancies have become clear over the last several years. Various drugs such as aspirin and the sera from some SLE patients are known to interfere with lymphocyte transformation (32, 35, 36) . To exclude these factors lymphocytes should be cultured in normal allogeneic serum and patients should, so far as can be ascertained, be taking no drugs. We originally studied patients on their initial visit to our Rheumatic Disease Clinic who were not receiving any drugs other than aspirin or oral contraceptives. The SLE patients in this study took no drugs for 2 days before the study.
The hypocomplementemic SLE group was lymphopenic in comparison to the normocomplementemic group and to age-and sex-matched controls. This lymphopenia was accounted for by absolute decreases in SIg, EAC, Fc, and E-rosetting cells; however, the percentages of these cells were not significantly different from normals. Previously, we, as well as others, had found a significant percentage decrease in T cells in SLE (23, 37, 38) . However, our previously studied SLE patients had disease of much longer duration than the patients reported here, and disease duration and activity may play a role in the T lymphopenia.
To help eliminate the possibility that potentially inhibitory serum factors were adhering to the mononuclear cells of the lupus patients, F-H-separated mononuclear cells were washed extensively and cultured at 37°C for 12 h. To further investigate Tand B-cell responsiveness, T and B lymphocytes were purified from peripheral blood. Three different separation methods for both T and B lymphocytes were used to avoid possible selective depletion of subpopulations during purification. We found that the proliferative response to PHA was similar with different methods, and therefore have presented data only for the separation method which we termed E rosette-forming cell "a" (E-RFC[a]) and for the separation methods for B lymphocytes which we call B-enriched(d).
Both cytofluorography and thymidine incorporation were used for the following reasons. First, lymphocytes themselves are not auxotrophic for thymidine. A small intracellular pool of thymidine monophosphate as a DNA precursor exists, produced by synthetic reactions from simple precursors such as aspartic acid. Thymidine added to a culture system uses an unknown transport system to enter the cell. The relative contribution of these two metabolic pathways to the pool of thymidine monophosphate is usually not known, and discrepancies between incorporation of labeled thymidine into DNA and the actuLal rate of DNA synthesis have been observed in several systems (39, 40 (44) .
The striking association of lymphopenia with lymphocytotoxic antibodies, and of lymphopenia with impaired mitogen responsiveness, suggests that some cells in our culture system may have been coated with lymphocyte membrane-determinant antigen antibodies (32, 44) . We attempted to eliminate this possibility by 370C washing of the cells followed by 370C incubations. We cannot exclude the possibility that residual cell-bound antibody or antigen-antibody complexes may be present and effect anchorage modulation of the cytoskeleton (46) . Our data concerning the density distribution of concanavalin A receptors strongly suggest that steric phenomena do not cause masking of the lectin receptor.
To clarify the abnormal transformation response further, we studied the other two cell types which are needed for an optimal response to PHA: monocytes and B lymphocytes. SLE The response of the whole mononuclear cell population to PHA was markedly improved by steroid treatment; this improvement involved both B-lymphocyte helper function and T-lymphocyte function, occurred early in the course of treatment, and was independent of clinical improvement. It is tempting to speculate that the prompt response to the steroids was due to a depletion of a suppressor cell population of cells, a population that has both T-and B-lymphocyte suppressor activities, or to removal of cell surfacebound protein, or immune complexes, similar to what has been postulated to occur in steroid-treated idiopathic thrombocytopenic purpura (51) .
The study of cellular contribution to abnormal lymphocyte proliferation in SLE may help in dissecting out the cellular contribution of abnormal responsiveness in a variety of disease states. There is strong evidence for abnormal T-cell function in SLE. However, abnormalities in B lymphocytes also appear to contribute to the decreased incorporation of [3H ]TdR noted. Monocytes exhibit abnormal phagocytic capabilities in the presence of lupus serum but appear to maintain at least some functional capabilities when cultured in autologous serum and appear only rarely to contribute to the abnormal PHA responsiveness noted.
